Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Grant/Award of 10,000 GOSS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| May 29, 2026 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 8,026 | n/a |
| Aug 20, 2025 | Gossamer Bio, Inc. (GOSS) | Purchase | 26,050 | $50.0K |
| Jun 26, 2025 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |
| Jun 2, 2025 | Spyre Therapeutics, Inc. (SYRE) | Grant/Award | 25,000 | n/a |
| Jan 8, 2025 | Aspira Women's Health Inc. (AWH) | Exercise/Conversion | 20,000 | n/a |
| Nov 14, 2024 | Aspira Women's Health Inc. (AWH) | Grant/Award | 25,000 | n/a |
| Oct 28, 2024 | Aspira Women's Health Inc. (AWH) | Grant/Award | 20,000 | n/a |
| Jun 7, 2024 | Gossamer Bio, Inc. (GOSS) | Grant/Award | 115,000 | n/a |